Citigroup’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2015
Q4
Sell
-134,779
Closed -$5.82M 5976
2015
Q3
$5.82M Sell
134,779
-23,100
-15% -$998K 0.01% 790
2015
Q2
$6.67M Buy
157,879
+151,670
+2,443% +$6.41M 0.01% 739
2015
Q1
$240K Buy
6,209
+1,659
+36% +$64.1K ﹤0.01% 2813
2014
Q4
$153K Buy
4,550
+184
+4% +$6.19K ﹤0.01% 3353
2014
Q3
$153K Sell
4,366
-52
-1% -$1.82K ﹤0.01% 2835
2014
Q2
$145K Buy
4,418
+605
+16% +$19.9K ﹤0.01% 2818
2014
Q1
$141K Sell
3,813
-528
-12% -$19.5K ﹤0.01% 3192
2013
Q4
$167K Buy
4,341
+1,692
+64% +$65.1K ﹤0.01% 3292
2013
Q3
$73K Sell
2,649
-4,028
-60% -$111K ﹤0.01% 3381
2013
Q2
$140K Buy
+6,677
New +$140K ﹤0.01% 3022